Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications.

Marco Heestermans, Géraldine Poenou, Hind Hamzeh-Cognasse, Fabrice Cognasse, Laurent Bertoletti

Journal: Cells 2022;11(20):3214

PMID: 36291080

Abstract

Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent) venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a century, and, nowadays, physicians possess a broad panel of multiple anticoagulants to meet the individual needs of a patient. Within this review, we aimed to revise the history of the different anticoagulants that are currently prescribed in the clinic. In addition, we compared their pharmacological properties, medical indications, and the difficulties in implementing new anticoagulants in vulnerable patient populations. Since the introduction of unfractionated heparin in the 1930s, major advances in the mechanistic understanding and the medical use of anticoagulants have allowed for significant improvements to treat VTE patients. However, a new generation of anticoagulants is currently being tested in clinical trials, with the goal of further optimizing medical care.

Address: French Blood Establishment (EFS) Auvergne Rhône Alpes-Scientific Department, F-42270 Saint-Etienne, France.; INSERM, U1059, SAINBIOSE, Jean Monnet University, F-42023 Saint-Etienne, France.; Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, F-42055 Saint-Etienne, France.; INSERM, CIC-1408, CHU Saint-Etienne, F-42055 Saint-Etienne, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.